News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Premier Allergist, formerly The Allergy & Asthma Center, Joins AllerVie Health and Expands AllerVie Footprint to 10 States and 64 Locations

AllerVie Health

Today, AllerVie Health, a national network of board-certified allergists and immunologists, welcomes Premier Allergist, formerly The Allergy & Asthma Center, to its national platform. With the addition of Premier Allergist, AllerVie adds 32 locations to its provider network, enters three new states, and densifies their existing presence in Virginia and Florida. Dr. Prasad M. Nataraj, MD, the owner and founder of Premier Allergist, joins AllerVie Health and will be serving in a new executive leadership role where his expertise in increasing access to care through allergy clinic growth will help propel the company’s national network expansion. Dr. Nataraj attended medical school at Jawaharlal Nehru Medical School in India, completed his residency at Cornell Hospital in New York, and completed fellowship at the Louisiana State University – Tulane combination program. Dr. Nataraj and his wife Radhika built Premier Allergist over the past 26 years through relentless dedication to their calling to provide patients with state-of-the-art techniques for treatment, testing, and diagnosis of allergy, asthma, and related immunological disorders. "We are thrilled to be able to expand our phenomenal patient base and the care we provide to our patients by partnering with AllerVie Health,” said Dr. Prasad M. Nataraj. “We look forward to utilizing their resources to improve care for our current patients and to amplify our reach to new patients in our current and new markets.” All Premier Allergist providers will continue to practice medicine and provide exemplary allergy and immunology services to patients from their current locations throughout Maryland, D.C, Virginia, Pennsylvania, and Florida, ensuring continuity of care for patients. By joining AllerVie Health, Premier Allergist will leverage AllerVie’s commitment to clinical research, innovation, and expansion of care allowing the combined organization to expand and enhance services to patients through new clinical research trials, innovative treatments, and other resources available across the nationwide network of providers. “AllerVie Health is a patient-first organization directed by and in support of board-certified allergists,” said Dr. Weily Soong, AllerVie Health Chief Medical Officer. “We believe that all people deserve access to evidence-based allergy diagnostics and treatments, as well as advancements in allergy therapeutics stemming from clinical research trials. With the inclusion of Premier Allergist to our network, we are thrilled to be adding new providers to our network who both believe and ensure that patients receive the best in life changing care every day - the ultimate AllerVie experience.” An organization of like-minded, patient-focused providers living out their commitment to improving people’s lives one patient at a time, AllerVie Health and Premier Allergist look forward to bringing more clinic access, job opportunities, and the gold standard of patient care to their communities. About AllerVie Health AllerVie Health is a national network of board-certified allergists and immunologists partnering together for the advancement of patient care, serving patients across 10 states in 64 clinic locations. Our providers are committed to establishing the allergy and immunology gold standard, expanding access to best-in-class care, and bringing relief and renewed vitality to the millions of Americans affected annually, many of whom live in underserved communities today. AllerVie is relentlessly dedicated to clinical excellence, creating an improved patient experience, and supporting the development of advanced allergy and immunology-focused therapeutics and treatment options. With AllerVie Health, our patients can feel their best, reclaim their lives, and live in freedom! To learn more, visit www.allervie.com. Contact Details Rachel Russell Chief Marketing Officer rrussell@allervie.com Weily Soong, MD Chief Medical Officer wsoong@allervie.com

December 06, 2021 12:00 PM Central Standard Time

Article thumbnail News Release

Hong Kong Successfully Hosts the 18th World Congress of Chinese Medicine for the First Time

Hong Kong Tourism Board

HONG KONG SAR - Media OutReach - 6 December 2021 - The 18th World Congress of Chinese Medicine (WCCM), one of the world's largest academic events in the field of Traditional Chinese Medicine (TCM), was successfully held in Hong Kong for the first time at the Hong Kong Convention and Exhibition Centre on 4 December 2021. Officiating guests including: the Hon Mrs. Carrie Lam Cheng Yuet-ngor, Chief Executive of the Hong Kong Special Administrative Region, the People's Republic of China (6th from left), Mr. C Y Leung, GBM, GBS, JP, Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference, the People's Republic of China (4th from right), Mr. Tan Tieniu, Vice Director of Liaison Office of the Central People's Government in the Hong Kong S.A.R. (4th from left), Professor Sophia Chan Siu-chee, JP, Secretary for Food and Health of Hong Kong Special Administrative Region, The People's Republic of China (3rd from right), Dr. Chui Tak-yi, JP, Under Secretary for Food and Health of Hong Kong Special Administrative Region, The People's Republic of China (3rd from left), Dr. Ronald Lam, JP, Director of Health of Hong Kong Special Administrative Region, The People's Republic of China (2nd from left), Dr. Margaret Chan Fung Fu-chun, former Director-General of the World Health Organization (2nd from right), Ms. Feng Jiu, Permanent President of Hong Kong Registered Chinese Medicine Practitioners Association (5th from left), Mr. Tommy Li Ying-sang, Chairman of the Federation of the Hong Kong Chinese Medicine Practitioners and Chinese Medicine Traders Association (1st from right), and Professor Lyu Aiping, Dean of School of Chinese Medicine, Hong Kong Baptist University (1st from left) joined hands to kick off The 18th World Congress of Chinese Medicine. The 18th World Congress of Chinese Medicine Thanks to the bidding efforts of the Hong Kong Registered Chinese Medicine Practitioners Association, which is a member of the Hong Kong Convention Ambassador (HKCA) programme, initiated by the Hong Kong Tourism Board (HKTB), in collaboration with the World Federation of Chinese Medicine Societies (WFCMS), the hybrid event attracted more than 2,000 TCM academics and experts, generated over 3.8 million views from over 60 countries and regions. As physical gatherings resumed for the first time since the pandemic started, WCCM provided a platform for participants to engage in meaningful dialogue, covering TCM practices, benefits, opportunities and challenges, and the development potential of TCM. Mr. Ma Jianzhong, President of WFCMS, said, "We are pleased to host this edition of WCCM in Hong Kong for the first time. Embracing Chinese philosophy and culture, Hong Kong is the ideal place for academic and cultural exchanges to explore the way forward for furthering the global development of TCM, and its role in combating the pandemic through collaboration between practitioners and public sectors." Mr. Sang Binsheng, Vice President and Secretary General of WFCMS added, "Hong Kong is renowned for being the 'World's Meeting Place' thanks to its globally accessible and convenient transport network, large-scale world-class venues, facilities and professional services. We look forward to gathering again in Hong Kong and navigating the future of TCM development together." With its unrivalled fundamentals, Hong Kong is the core international city in the Greater Bay Area, a super-connector in the Belt and Road Initiative, and the ideal platform to promote TCM on the global stage. HKTB Executive Director Mr Dane Cheng said, "Hong Kong enjoys unique geographical and cultural advantages, and is the ideal destination for international conventions. Many such events have taken place recently, demonstrating Hong Kong's ability to host large-scale global events safely and efficiently. Apart from TCM, Hong Kong will continue to leverage the city's advantages as an East-meets-West showcase to promote the very best of Chinese heritage." The congress received extensive support from government and industry bodies. The National Administration of TCM and the Hong Kong Food and Health Bureau acted as advisors, and it was organised by the WFCMS, along with the Hong Kong Registered Chinese Medicine Practitioners Association and the WFCM (Hong Kong) Council Members Association as local hosts. Hong Kong – A World-Class Medical Convention Hub Hong Kong is a cultural melting pot, bringing together the best that the world has to offer, demonstrating the true definition of 'East meets West', even in the field of medicine. With its high global professional standing in medical science, Hong Kong plays a bridging role to contribute to the further development of TCM, as well as many Western medical disciplines. This winter, the city will also play host to key medical conventions, including the International Annual Congress of the Endoscopic and Laparoscopic Surgeons of Asia (ELSA) 2021, and the Hong Kong International Dental Expo and Symposium (HKIDEAS) 2021, both of which are led by Convention Ambassadors of the two organisations under the HKCA programme. About the Hong Kong Convention Ambassador (HKCA) programme Initiated by the HKTB, the HKCA programme brings together distinguished leaders from business and professional bodies to make Hong Kong the premier choice for regional and global meetings, conventions and exhibitions. HKTB provides comprehensive professional support and services to HKCAs, from event planning, bidding and preparation to execution. For more details, visit www.mehongkong.com/hkca. Contact Details Hong Kong Tourism Board Ms Vanessa So +852 2807 6540 vanessa.so@hktb.com

December 06, 2021 09:00 AM Eastern Standard Time

Image
Article thumbnail News Release

How to Figure Out Medicare and Choose the Right Plan

YourUpdateTV

Choosing a Medicare plan can feel overwhelming. Ten thousand baby boomers age into Medicare everyday with questions about getting the right, affordable healthcare coverage and finding a Medicare plan that fits their needs. Recently, Keira Krausz, the Chief Marketing Officer at ClearMatch™ Medicare, part of HealthPlanOne, teamed with YourUpdateTV on a satellite media tour to share tips on how to make this year’s Medicare enrollment less confusing. A video accompanying this announcement is available at: https://youtu.be/58vAvLAhVyIQ For nearly 63 million Medicare beneficiaries or individuals turning 65 who need affordable health plan coverage, Medicare’s Annual Enrollment Period is here, and it will end in December 7 th. Choosing a Medicare plan can feel overwhelming. According to a recent survey, 58 percent of Medicare members say they don’t look forward to reviewing their Medicare plan, with 23 percent of people sharing that reviewing their plan is as delightful as having a colonoscopy. In 2019, 71 percent of Medicare beneficiaries said they didn’t compare plans during the open enrollment period, according to a Kaiser study published last month. Not comparing plans is a missed opportunity – because each year plans and benefits change – it’s important for individuals to compare their options, and a broker like ClearMatch™ Medicare can easily provide you a simple comparison of best plans. ClearMatch™ Medicare is committed to “de-complexify” Medicare for customers across the country. They match each customer with the right plan at the right place to deliver better health and peace of mind. The company can support customers throughout their Medicare journey, with a focus on the long-term. ClearMatch agents guide customers at every step of the way, from identifying and enrolling in a plan to reviewing coverage each year to make sure customers get all the benefits they deserve. To learn more about this year’s Medicare’s Annual Enrollment period and ClearMatch™ Medicare, go to: clearmatchmedicare.com About Keira Krausz: An award-winning Direct-to-Consumer marketer, Krausz has spent her career focused on the melding of data-driven analytics and compelling creative. Krausz led the launch of the ClearMatch™ Medicare brand. The brand’s purpose is to match each customer with a Medicare plan that delivers the benefits the customer is entitled to, to support better health and deliver peace of mind. The company expects potential customers will benefit from its digital content and then leverage a hybrid approach – an ecommerce platform plus a licensed ClearMatch™ Medicare insurance agent – to gain a solid understanding of options and enroll in a plan. ClearMatch™ Medicare agents, supported by the company, then will build a long-term relationship with each customer to ensure satisfaction. From 2013-2018 Krausz was the CMO and EVP of Nutrisystem, Inc., where her team reversed a seven-year decline and returned the company to sustained growth, to nearly double revenue and quadruple EBITDA. Prior to Nutrisystem, Krausz held leadership positions at Time Inc. and the Reader’s Digest Association, Inc. Krausz attended Cornell University as an undergraduate and has an MBA from the Tuck School at Dartmouth College. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

December 03, 2021 12:00 PM Eastern Standard Time

Video
Article thumbnail News Release

COMCAST'S INTERNET ESSENTIALS PROGRAM AND SERJOBS ANNOUNCE TECHNICAL SKILLS TRAINING PARTNERSHIP AND $30,000 DONATION

Comcast Houston

Comcast's Internet Essentials program today announced the award of a $30,000 financial grant and donated 1,000 laptops to SERJobs, whose mission is to help individuals from low-income communities transform their lives through education training, employment, and financial empowerment services. The grant and donation are part of a new partnership to fund technical skills training and readiness certifications for clients of SERJobs. This program will offer digital skills training opportunities, including Microsoft Office, PowerPoint, Excel and professional development. “SERJobs is excited to celebrate 10 years of Comcast's Internet Essentials program,” said Sheroo Mukhtiar, CEO, SERJobs. “The Workforce Development Rally highlights the importance of digital literacy in our increasingly virtual world—especially as technology and the needs of our economy evolve. We are grateful to Comcast for their ongoing partnership and support of SERJobs’ and our members.” The announcement is part of Project UP, Comcast’s comprehensive initiative to advance digital equity and help build a future of unlimited possibilities; and coincides with the 10th anniversary of its Internet Essentials program, which has connected a cumulative total of more than 10 million people to the Internet at home – most for the very first time. Comcast’s expanded eligibility for Internet Essentials, now including all Federal Pell Grant recipients within its service area, will enable even more students to stay connected as they continue to pursue degrees at colleges, universities, and technical schools. “Ten years is a remarkable milestone, signifying an extraordinary amount of work and collaboration with our incredible community partners across Houston,” said Toni Beck, Vice President of External Affairs, Comcast Houston. “Together, we have connected hundreds of thousands of people to the power of the Internet at home, and to the endless opportunity, education, growth, and discovery it provides. Our work is not done, and we are excited to partner with SERJobs to ensure the next generation of leaders in Houston are equipped with the technical training they need to succeed in an increasingly digital world.” Comcast’s top priorities are connecting people to the Internet at home, equipping safe spaces with free WiFi and working with a robust network of nonprofit community organizations, city leaders, and business partners to create opportunities for low-income Americans. As the nation’s largest internet provider, Comcast supports cooperation between communities, businesses and non-profit organizations to enhance digital equity. Comcast’s $1 billion commitment will include investments in several critical areas, including: additional support for the Lift Zone initiative, which establishes free WiFi access in 50 community centers in Houston, and 1,000+ community centers nationwide, for students and adults by the end of 2021; new laptop and computer donations; over $100,000 in digital equity grants for local Houston nonprofit community organizations to create opportunities for low-income Houstonians – particularly in media, technology, and entrepreneurship; and continued investment in the company’s landmark Internet Essentials program. Project UP & Comcast’s $1 Billion Commitment to Advancing Digital Equity: For over a decade, connecting more people to the Internet and the technology they need to participate and excel in an increasingly digital world has been a core focus for the company. Looking toward the next ten years, Comcast is building on that foundation and expanding its impact through Project UP, a comprehensive initiative to advance digital equity and help build a future of unlimited possibilities. Backed by a $1 billion commitment to reach 50 million people, Project UP encompasses the programs and community partnerships across Comcast, NBCUniversal, and Sky that connect people to the Internet, advance economic mobility and open doors for the next generation of innovators, entrepreneurs, storytellers, and creators. For more information on Project UP and the latest news on efforts to address digital inequities visit https://corporate.comcast.com/impact/project-up. About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company that connects people to moments that matter. We are principally focused on broadband, aggregation, and streaming with over 57 million customer relationships across the United States and Europe. We deliver broadband, wireless, and video through our Xfinity, Comcast Business, and Sky brands; create, distribute, and stream leading entertainment, sports, and news through Universal Filmed Entertainment Group, Universal Studio Group, Sky Studios, the NBC and Telemundo broadcast networks, Peacock, NBC News, NBC Sports, Sky News, and Sky Sports; and provide memorable experiences at Universal Parks and Resorts in the United States and Asia. Visit www.comcastcorporation.com for more information. About SERJobs: SERJobs Houston, a regional affiliate of SER Jobs for Progress National, Inc., is a nonprofit organization empowering individuals to transform their lives through education, training, employment, and financial empowerment services. Founded in 1965 as a volunteer job bank for Hispanic veterans, SERJobs has evolved, and now operates offices in Houston, Galveston and Fort Bend. SERJobs serves individuals in 13 Texas counties and assists more than 4,000 members access better opportunities every year. For more information, visit serjobs.org Contact Details Comcast Foti Kallergis +1 832-986-0196 Foti_Kallergis@comcast.com SERJobs Christi Vasquez +1 832-890-3606 Company Website https://houston.comcast.com/

December 02, 2021 09:01 AM Central Standard Time

Article thumbnail News Release

Regenerative Medicine Company Vascudyne Closes $10 Million Series A Financing

Vascudyne, Inc.

Investment will support expanded clinical trials of TRUE Graft, establish a commercial GMP manufacturing facility, and further develop the TRUE Tissue platform technology for additional products. Vascudyne, Inc., a biotechnology trailblazer in regenerative medicine, announced today that it has raised $10 million Series A cash financing through a global group of investors. In July, Vascudyne also announced the successful first human use of TRUE™ Graft for hemodialysis access in end-stage renal disease patients. Vascudyne’s early product development and preclinical studies were funded by angel investors. Since incorporation, Vascudyne transferred the regenerative technology, vertically integrated manufacturing, and launched TRUE Graft’s first human use clinical trial. Vascudyne’s TRUE to Nature™ biomaterials are unique and 100% natural. While other regenerative medicine cardiovascular devices contain synthetic polymer-based scaffolds that slowly degrade in the body and may lead to adverse immune response, Vascudyne’s TRUE™ Tissue technology is 100% biological: nothing synthetic or artificial is ever used in the manufacturing process. “We are thrilled that investors share our passion for bringing our TRUE Tissue platform technology to patients worldwide,” shared Rick Murphy, VP of Operations and GM of Vascudyne. “We are scaling up our GMP manufacturing facility to support the expansion of the clinical safety study of our TRUE Graft for hemodialysis access and accelerate new products towards clinical use that are currently in development for multiple cardiovascular applications.” “Closing the Series A finance round is a very exciting milestone for Vascudyne,” said Kem Schankereli, Chief Executive Officer of Vascudyne. “We are gaining momentum and paving the way to being able to supply our TRUE Tissue regenerative material technology to patients in need. The Series A funding provides the needed support to grow the organization so we can continue our clinical trials, expand operations, and translate additional products using our TRUE technology platform from pre-clinical to clinical trials.” Vascudyne licensed its proprietary TRUE Tissue technology developed by world renowned tissue engineering leader Robert Tranquillo, PhD, Distinguished McKnight University Professor, and his colleagues from the University of Minnesota in 2017. The TRUE Graft is not available for commercial sale. About Vascudyne Headquartered in the heart of Medical Alley in Minnesota, Vascudyne is on a mission to improve patient care with regenerative biomaterials that are inspired by nature. Vascudyne, a privately held company founded in 2014, uses the TRUE™ Tissue technology to develop TRUE to Nature™ biomaterials for soft tissue repair and replacement. For more information, please visit https://www.vascudyne.com/. About TRUE Tissue Technology TRUE™ Tissue is developed from cells isolated from donor tissue and is 100% biological. There are no synthetic materials or chemical fixation used, and implanted tissues are completely cell-derived and acellular. The TRUE Tissue technology can be readily shaped into tubes, sheets, and other geometries making it suitable for many soft tissue applications, is mechanically comparable to native tissues, and is a ready to use, off-the-shelf allograft. Forward Looking Statements This announcement contains forward-looking statements. Such statements may include, without limitation, statements identified by words such as "projects," "may," "will," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "potential" or similar expressions. These statements relate to future events or Vascudyne’s clinical development programs, reflect management’s current beliefs and expectations and involve known and unknown risks, uncertainties and other factors that may cause Vascudyne’s actual results, performance or achievements to be materially different. Vascudyne undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future presentations or otherwise, except as required by applicable law. Contact Details Vascudyne Sandy Williams, Marketing Director +1 952-412-5975 swilliams@vascudyne.com Company Website https://vascudyne.com/

December 02, 2021 09:23 AM Eastern Standard Time

Image
Article thumbnail News Release

As Great Resignation Escalates, Maven Clinic and Great Place to Work® Release Study on What Parents Want in the New World of Work

Great Place to Work®

Great Place to Work ®, the global authority on workplace culture, and Maven Clinic, the world's largest virtual clinic for women's and family health, released “Working Parents, Burnout & the Great Resignation,” a report based on the largest-ever survey of working parents. Drawing on the responses of 493,082 working parents from more than 1,700 US-headquartered companies, “Working Parents, Burnout & the Great Resignation” represents the authoritative look at what parents want in the new world of work. The new research comes at a time when the Great Resignation has reached new depths as recent reports suggest that 65% of employees in the US are actively searching for new opportunities. With parents making up 40% of the US economy, working mothers and fathers are no exception to this trend. As parents reconsider their relationship with work, companies face growing and new pressures to win the talent war for this key part of the workforce. “This report shows that the Great Resignation is fundamentally a crisis of recognition,” said Kate Ryder, founder and CEO of Maven. “Working parents who feel included within a company's culture and empowered in its long-term strategy are far more likely to stay with their employer. The companies that think about their employees’ experience holistically — the challenges at home, the opportunities at work — are set to leapfrog their peers in the post-pandemic economy.” “Working parents are a key talent demographic that can help companies thrive, and business leaders who see it this way are at a powerful advantage” said Michael Bush, CEO of Great Place to Work. “Our research with Maven shows that ensuring working parents experience a great place to work for all can be achieved if employers shift their focus to the five key drivers to attract, retain and sustain working parents. Ultimately, companies that embrace strategies to ensure this talent group thrives long into the future have the potential to see 5.5 times more revenue growth.” The Great Place to Work-Maven report offers valuable insights about what matters most to parents —personalized support, fairness and inclusivity—and provides data-driven strategies for employers to emerge as leaders of the new way of working. Key findings from the report include: Burnout continues unabated, which means the resignation wave is far from over. Employees who experience burnout are more than twice as likely to resign their positions. The report finds that 4.8 million working parents are experiencing burnout as the year comes to a close. A holistic approach to employee wellbeing can prevent 4 out of 5 working parents from quitting. By studying the top-performing workplaces, the report identifies five key drivers of retaining and sustaining working parents, positioning this group for long-term growth. The Best Workplaces for Parents™ are doubling down on benefits — and seeing the results. Organizations that were perceived as offering ‘special and unique’ benefits were 2x as likely to retain parents. Three in four (75%) Best Workplaces are providing support for fertility programs and 66% offer adoption support. Many Best Workplaces are also offering benefits like egg freezing coverage (58%), subsidize child care expenses (44%), and provide surrogacy coverage (43%). Burnout has especially impacted mothers of color and young parents who are hourly workers, underscoring how the pandemic has exacerbated deep-seated inequities in the US. The report found that BIPOC mothers are 35% more likely to experience burnout, and younger parents between 26-34 working hourly roles are 200% more likely to experience burnout. The report is part of a multi-year partnership between Maven and Great Place to Work and marks the second annual study released by the two companies. The launch of “Working Parents, Burnout & the Great Resignation” also coincides with the release of Great Place to Work's annual Best Workplaces for Parents™ list, celebrating the 100 companies whose support for parents has stood out over the past year. Visit: https://www.greatplacetowork.com/best-workplaces-parents About Maven Clinic Maven is the largest virtual clinic for women's and family health, offering continuous, holistic care for fertility, pregnancy and parenting. Maven's award-winning digital programs are trusted by leading employers and health plans to reduce costs and drive better health outcomes for both parents and children. Founded in 2014 by CEO Kate Ryder, Maven has been recognized as Fast Company's #1 Most Innovative Health Company and has supported more than 10 million women and families to date. Maven has raised more than $200 million in funding from leading investors including Sequoia, Oak HC/FT, Dragoneer Investment Group and Lux Capital. To learn more about how Maven is reimagining life's most critical healthcare moment, visit us at mavenclinic.com. About Great Place to Work® Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees around the world and used those deep insights to define what makes a great workplace: trust. Great Place to Work helps organizations quantify their culture and produce better business results by creating a high-trust work experience for all employees. Everything they do is driven by the mission to build a better world by helping every organization become a Great Place to Work For All™. To learn more, visit greatplacetowork.com, listen to the podcast Better by Great Place to Work, and read A Great Place to Work For All. Join the community on LinkedIn, Twitter, and Instagram. Learn more: https://www.greatplacetowork.com Contact Details Kim Peters +1 415-844-2574 support@greatplacetowork.com

December 02, 2021 09:00 AM Eastern Standard Time

Image
Article thumbnail News Release

UK SMEs forge ahead with cautious optimism as post-pandemic business confidence grows

Stockwood Strategy

Despite lingering anxieties about the pandemic and a variety of economic and commercial issues, the majority of SMEs believe it is now imperative to begin building back from the crisis. They are ready to step up their business investment, with ambitious plans for recruitment, renewal of equipment and machinery, and both domestic and international expansion. Fintech business lender MarketFinance asked 2,000 SME owners across the UK about their outlook for 2022 and beyond, gauging their short and long-term plans for business investment and growth. MarketFinance has today released a comprehensive research report of its findings. Confidence Analysis of the survey results has shown that business confidence amongst SMEs is improving, with many firms now focused on recovery and growth. With pandemic disruptions now largely settled, half of SMEs (48%) expect their turnover to stabilise or to increase over the next 12 months. Similarly, 50% of SMEs expect demand for their products or services to stabilise or to increase over the next six months. MarketFinance’s research has found that the majority of SMEs (63%) expect their business to grow over the next three years Investment With survival mode no longer a necessity and cash flow pressures beginning to ease, the vast majority of SMEs (70%) now feel confident enough to increase business investment over the next 12 months. A quarter of SMEs plan to hire new staff, while 24% expect to purchase new equipment and machinery. When asked how they were factoring borrowing into their investment plans, 23% of SMEs said access to a broader range of borrowing options could enable them to increase investment even further. Borrowing The research findings demonstrate that borrowing will play a key role in recovery and growth with 62% of SMEs saying that prudent borrowing could help them fund growth. However, three quarters (71%) of SMEs do not believe traditional banking products are the most obvious and convenient way to borrow for investment. Despite this lack of alignment between current finance needs and the options available through traditional routes, more than a third of SMEs (37%) are looking to take on new borrowing facilities. Growth With confidence high and a sense of having moved beyond recovery and into a new stage of growth, many businesses are looking forward to seizing a host of opportunities in 2022. Almost all SMEs surveyed (81%) plan to invest in sustainability, while 30% say they are considering merger and acquisition (M&A) activity in the year ahead – more than twice as many as those primarily focusing on organic growth (14%). Over a third of businesses (34%) say they already sell overseas, or have plans to begin doing so. That figure is highest amongst the largest businesses surveyed (turnover between £5m and £6.5m) but even amongst smaller enterprises significant numbers are focused on export. Anil Stocker, CEO at MarketFinance, commented: “ It’s clear that the business environment has shifted and SMEs are looking ahead with a quietly confident and cautiously optimistic view. UK businesses intend to ramp up growth through domestic and international expansion, digital transformation and even M&A activity. But as they reset their post-pandemic goals for a post-pandemic, they’ll need to be confident of their funding base. Given that so many SMEs are looking outside of traditional routes in their search for finance, we’re particularly proud to have been accredited by the British Business Bank as one of the few alternative providers under The Recovery Loan Scheme. Schemes like the RLS are a golden opportunity for SMEs looking to gear up for growth, providing easily accessible funding at a lower cost across a wide range of products. We expect to see a large number of SMEs taking advantage of the scheme over the next 6 months as their growth and expansion efforts gain momentum and they invest in ambitious plans for 2022 and beyond.” About MarketFinance MarketFinance is a fintech business lender which believes that SMEs are building the world. By making finance frictionless, they’re solving the cash flow issues getting in the way of progress. MarketFinance uses smart technology to deliver better access to faster, more affordable finance; with one-to-one help whenever businesses need it. Since 2011, MarketFinance has advanced over £2.6 billion worth of invoices and loans, enabling thousands of UK businesses to bridge today’s funding gaps and fuel tomorrow’s big ambitions. MarketFinance is an accredited Recover Loan Scheme lender and has a wide-reaching network of strategic partners including Barclays Bank UK PLC, Tide, Equals Group and Ebury. MarketFinance is backed by Barclays Bank UK PLC, Mouro Capital, Paul Forster (co-founder of Indeed.com) European venture capital fund Northzone (invested in Klarna, iZettle and Trustpilot), Viola Capital and private equity group MCI Capital (also invested in iZettle, Azimo and Gett). Further information visit: www.marketfinance.com Contact Details MarketFinance Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://marketfinance.com/

December 01, 2021 08:00 AM Eastern Standard Time

Image
Article thumbnail News Release

G Medical Innovations Holdings Ltd. Scheduled to Launch Covid-19 Testing Centers in California as Part of New Direct-to-Consumer Initiative

G Medical Innovations Holdings

G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, today announced plans to open as many as 25 Covid-19 testing centers in California in Q1, 2022. Known for its groundbreaking technology, remote patient monitoring devices and services utilized by hospitals and cardiologists across the country, GMedical’s innovative Prizma monitoring device will be offered direct-to-consumer for the first time at these testing locations, as part of an aggressive company direct-to-consumer strategy. Prizma is a user-friendly cell phone-sized device that can help monitor user’s vital signs, providing to-the-minute readings for ECG, temperature, oxygen saturation, heart rate, stress levels and blood pressure, help track body weight and glucose levels. Data is presented directly to the user and the designated care provider. G Medical’s remote patient monitoring center can alert users to readings that may be a cause for concern. Prizma can also be prescribed by physicians to patients with cardiac or respiratory disease, diabetes and other health issues. With the explosive growth in demand for Covid testing across the country, G Medical expects its new California locations to boost Prizma sales. “By offering Prizma at our Covid19 testing sites we are empowering consumers to measure and monitor their vital signs post testing, in the comfort of their own home,” said G Medical CEO Dr. Yacov Geva. “This unique opportunity to introduce our Prizma device to customers face-to-face at the point of sale is an important step forward in our company’s direct-to-consumer initiative.” Prominent Santa Monica physician Dr. Rand McClain agrees. “G Medical’s Prizma vital sign monitoring device can provide ‘next level’ of care, by empowering patients to measure and record their vital signs daily.” Telehealth services and the use of remote patient monitoring more than doubled from 2018 to 2020, and that growth continues, according to a recent report by the American Medical Association (AMA). Within this industry, G Medical Innovations is well positioned as a next-generation mobile health (mHealth) and e-health company that develops and markets its clinical and consumer medical-grade health monitoring solutions, and offers end-to-end support for e-health projects. With extensive experience in the field of digital health and project management, GMedical Innovations is committed to raising the global level of healthcare by empowering caregivers and patients to better monitor, manage and improve clinical and personal health outcomes. About G Medical Innovations Holdings Ltd. G Medical Innovations Holdings Ltd. Is an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms. The Company’s solutions and services can empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease and diabetes. The Company’s current product lines consist of its Prizma medical device (or Prizma), a clinical grade device that can transform almost any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography (or ECG) data continuously, including its QT Syndrome Prolongation Detection Capabilities Patch. In addition, the Company is developing its Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous and real time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (or IDTF) monitoring services and private monitoring services. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on G Medical’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of G Medical could differ materially from those described in or implied by the statements in this press release. For example, G Medical is using forward-looking statements when it discusses plans to open as many as 25 Covid-19 testing centers in California in Q1, 2022, its direct-to-consumer strategy and the benefits and advantages of its Prizma medical device. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in G Medical’s prospectus filed pursuant to Rule 424(b)(4), filed with the Securities and Exchange Commission (“SEC”) on June 28, 2021, and in any subsequent filings with the SEC. Except as otherwise required by law, G Medical undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. G Medical is not responsible for the contents of third-party websites. Contact Details G Medical Innovations Holdings Ltd. G Medical Service +972 8-958-4777 service@gmedinnovations.com Company Website https://gmedinnovations.com/

December 01, 2021 07:15 AM Eastern Standard Time

Article thumbnail News Release

EXCHANGE LISTING, LLC ASSISTS ADVANCED HUMAN IMAGING TO LAUNCH ITS AMERICAN DEPOSITARY RECEIPTS ON NASDAQ

Exchange Listing

Exchange Listing, LLC announced that its client, Advanced Human Imaging (Advanced Human Imaging or “The Company”), a rapidly growing medical technology company has commenced its listing on the Nasdaq Capital Market (“Nasdaq”) with American Depositary Receipts (“ADR’s”). Based in Perth, Australia, American Human Imaging, is a cutting-edge mHealth technology enterprise that uses artificial intelligence to make human scanning possible from a smartphone. The Company’s ADRs commenced trading on NASDAQ on November 19th, 2021 under the ticker symbol, (NASDAQ: AHI). The pricing of the Company’s U.S. initial public offering of 1,000,000 units is at a price to the public of US$10.50 per unit. Each unit issued in the offering consisted of two American Depositary Shares ("ADSs") and one warrant to purchase one ADS. Each ADS offered represents 7 ordinary shares of AHI. The warrants are exercisable immediately, and expires three years from the date of issuance and have an exercise price of US$5.52 per ADS. The ADSs and warrants are immediately separable and were issued separately. Gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, were approximately US$10.5 million. The Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ADSs and/or up to an additional 150,000 warrants to purchase up to 150,000 ADSs at the public offering price, less underwriting discounts, and commissions. “ Exchange Listing was instrumental in our achieving a listing on Nasdaq, the world's most prestigious platform for emerging growth companies,” said Vlado Bosanac. “Their guidance and knowledge was immensely valuable throughout the early stages of this complex process. This important step for AHI will allow us to increase liquidity and gain exposure for the Company with institutional and retail investors in the United States.” “Clearly, Advanced Human Imaging has transformed a smartphone into a health risk assessment tool,” said Peter Goldstein, CEO, Exchange Listing. “ The Company’s revolutionary technology can be used to assess and capture chronic disease risks or more simply track fitness goals in under one minute. There’s no doubt about the product's innovation and tremendous U.S. market potential.” Exchange Listing provides companies with cost-effective and efficient direct access to one-stop solutions in the strategic planning and implementation of listing and up-listing on senior exchanges such as the Nasdaq or NYSE. Focusing on company-specific structuring to meet listing requirements, Exchange Listing serves as the primary point of contact with the exchange, investment bankers and lawyers throughout the listing process. With extensive experience in investment banking, securities law, corporate governance and business management, Exchange Listing and its strategic partners facilitate clients' listing and capital markets objectives. About Exchange Listing Exchange Listing provides growth companies with direct access to a one-stop solution in the strategic planning and implementation of listing on a senior exchange such as NASDAQ or NYSE in a cost effective and efficient process. We assist clients in going public whether through an initial public offering, listing from another marketplace, merger or direct offering. We serve as the primary point of contact with the exchange, investment bankers, lawyers and other service providers. Our founders, strategic partners and advisors are entrepreneurs with backgrounds in investment banking, securities law, corporate governance and business management and have served as officers and directors of public and private companies. We pride ourselves in taking a hands-on role with our clients throughout the listing process. For more information, please visit: www.exchangelistingllc.com or contact info@exchangelistingllc.com. About Advanced Human Imaging: AHI has developed and patented a proprietary dimensioning technology that enables its users to check, track, and assess their dimensions in conjunction with known health risk indicators using only a smartphone both privately and accurately. Our goal is to assist our partners by empowering their consumers with this capability. This in return gives our partners the ability to assess, assist, and communicate outcomes with their consumers when navigating day to day life. Whether this is a personal journey to better health, understanding the risk associated with their physical condition, tracking the changes they are experiencing through training, dieting, or under medical regimes, or simply wanting to be correctly sized for a garment when shopping online. The AHI technology delivers this seamlessly, privately, and cost-effectively in under one minute. AHI has developed this capability by leveraging the power of Computer Vision, Machine Learning, and patented algorithms, to process the images and assessments on secure, enterprise-level infrastructure, delivering an end-to-end experience that is unrivalled in the industry. AHI simplifies the collection of measurements and removes the human error present in traditional methods. Contact Details WantLeverage Communications Julie Livingston +1 347-239-0249 julie@wantleverage.com Company Website https://exchangelistingllc.com/

November 29, 2021 08:07 AM Eastern Standard Time

12345 ... 48